These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34806430)

  • 1. Appropriateness of Using Vitamin K for the Correction of INR Elevation Secondary to Hepatic Disease in Critically ill Patients: An Observational Study.
    Al Sulaiman K; Al Mutairi M; Al Harbi O; Al Duraihim A; Aldosary S; Al Khalil H; Al Shaya A; Al Harbi S; Alotaibi N; Al Aamer K; Vishwakarma R; Al Asiri M; Aljuhani O; Al Katheri A; Al Bekairy AM
    Clin Appl Thromb Hemost; 2021; 27():10760296211050923. PubMed ID: 34806430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effectiveness of intravenous vitamin K in correcting cirrhosis-associated coagulopathy.
    Rivosecchi RM; Kane-Gill SL; Garavaglia J; MacLasco A; Johnson H
    Int J Pharm Pract; 2017 Dec; 25(6):463-465. PubMed ID: 28211589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Vitamin K Administration on Elevated International Normalized Ratio in Chronic Liver Disease.
    Smith CB; Hennessey EK; Crossey CD; Crannage AJ
    Clin Appl Thromb Hemost; 2023; 29():10760296231164642. PubMed ID: 37093741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Fresh-Frozen Plasma, Four-Factor Prothrombin Complex Concentrates, and Recombinant Factor VIIa to Facilitate Procedures in Critically Ill Patients with Coagulopathy from Liver Disease: A Retrospective Cohort Study.
    Kwon JO; MacLaren R
    Pharmacotherapy; 2016 Oct; 36(10):1047-1054. PubMed ID: 27547916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prothrombin complex concentrates to reverse warfarin-induced coagulopathy in patients with intracranial bleeding.
    Cabral KP; Fraser GL; Duprey J; Gibbons BA; Hayes T; Florman JE; Seder DB
    Clin Neurol Neurosurg; 2013 Jun; 115(6):770-4. PubMed ID: 22835715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of vitamin K on prothrombin time in critically ill patients: an observational registry study.
    Dahlberg S; Schött U; Kander T
    J Intensive Care; 2021 Jan; 9(1):11. PubMed ID: 33461606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefoperazone-induced Coagulopathy in Critically Ill Patients Admitted to Intensive Care Unit.
    Gudivada KK; Krishna B; Sampath S
    Indian J Crit Care Med; 2023 Mar; 27(3):183-189. PubMed ID: 36960109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose oral vitamin K is safe and effective for outpatient management of patients with an INR>10.
    Gunther KE; Conway G; Leibach L; Crowther MA
    Thromb Res; 2004; 113(3-4):205-9. PubMed ID: 15140584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial.
    Crowther MA; Julian J; McCarty D; Douketis J; Kovacs M; Biagoni L; Schnurr T; McGinnis J; Gent M; Hirsh J; Ginsberg J
    Lancet; 2000 Nov; 356(9241):1551-3. PubMed ID: 11075768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin K in the treatment of warfarin-associated coagulopathy. A randomized, controlled trial.
    Crowther MA; Douketis JD; Schnurr T; Steidl L; Mera V; Ultori C; Venco A; Ageno W
    Ann Intern Med; 2002 Aug; 137(4):251-4. PubMed ID: 12186515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction of international normalised ratio in major bleeding related to vitamin K antagonists is associated with better survival: A UK study.
    Tan J; MacCallum P; Curry N; Stanworth S; Tait C; Morris JK; Green L
    Thromb Res; 2021 Jan; 197():153-159. PubMed ID: 33220564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Vitamin K Administration on INR Changes and Bleeding Events Among Patients With Cirrhosis.
    Meyer AV; Green M; Pautler HM; Korenblat K; Deal EN; Thoelke MS
    Ann Pharmacother; 2016 Feb; 50(2):113-7. PubMed ID: 26586854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of warfarin-associated coagulopathy with vitamin K.
    Patriquin C; Crowther M
    Expert Rev Hematol; 2011 Dec; 4(6):657-65; quiz 666-7. PubMed ID: 22077529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low dose oral vitamin K to reverse acenocoumarol-induced coagulopathy: a randomized controlled trial.
    Ageno W; Crowther M; Steidl L; Ultori C; Mera V; Dentali F; Squizzato A; Marchesi C; Venco A
    Thromb Haemost; 2002 Jul; 88(1):48-51. PubMed ID: 12152676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.
    Bussey HI; Bussey M; Bussey-Smith KL; Frei CR
    Pharmacotherapy; 2013 Nov; 33(11):1136-46. PubMed ID: 24038412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor correlation of supratherapeutic international normalised ratio and vitamin K-dependent procoagulant factor levels during warfarin therapy.
    Sarode R; Rawal A; Lee R; Shen YM; Frenkel EP
    Br J Haematol; 2006 Mar; 132(5):604-7. PubMed ID: 16445834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the efficacy and safety profiles of intravenous vitamin K and fresh frozen plasma as treatment of warfarin-related over-anticoagulation in patients with mechanical heart valves.
    Yiu KH; Siu CW; Jim MH; Tse HF; Fan K; Chau MC; Chow WH
    Am J Cardiol; 2006 Feb; 97(3):409-11. PubMed ID: 16442406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin K dosing to reverse warfarin based on INR, route of administration, and home warfarin dose in the acute/critical care setting.
    Tsu LV; Dienes JE; Dager WE
    Ann Pharmacother; 2012 Dec; 46(12):1617-26. PubMed ID: 23249867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of coumarin-associated coagulopathy: a systematic review and proposed treatment algorithms.
    Dentali F; Ageno W; Crowther M
    J Thromb Haemost; 2006 Sep; 4(9):1853-63. PubMed ID: 16961594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of Vitamin K Antagonist (VKA) effect in patients with severe bleeding: a French multicenter observational study (Optiplex) assessing the use of Prothrombin Complex Concentrate (PCC) in current clinical practice.
    Desmettre T; Dehours E; Samama CM; Jhundoo S; Pujeau F; Guillaudin C; Hecquart C; Clerson P; Crave JC; Jaussaud R
    Crit Care; 2012 Oct; 16(5):R185. PubMed ID: 23036234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.